Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00616772
Other study ID # M10-158
Secondary ID
Status Completed
Phase Phase 3
First received
Last updated
Start date February 2008
Est. completion date September 2012

Study information

Verified date December 2013
Source AbbVie
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The primary purpose of this study is to test the effect and safety of once daily ABT-335 on the thickness of the lining of the carotid artery (a blood vessel to the brain) in patients with abnormal blood lipids who have optimal levels of low density lipoprotein cholesterol ("bad cholesterol") after taking atorvastatin.


Recruitment information / eligibility

Status Completed
Enrollment 682
Est. completion date September 2012
Est. primary completion date September 2012
Accepts healthy volunteers No
Gender All
Age group 45 Years and older
Eligibility Inclusion Criteria:

- Patients with mixed dyslipidemia

- Qualifying cIMT thickness

Exclusion Criteria:

- Patients with certain chronic or unstable medical conditions.

- Patients with unstable dose of medications or receiving coumadin, cyclosporine, or certain other medications

- Pregnant or lactating women or women intending to become pregnant

- Patients with diabetes mellitus that is poorly controlled

Study Design


Intervention

Drug:
ABT-335
Capsule
Placebo
Capsule
Other:
Atorvastatin
Capsule

Locations

Country Name City State
United States Site Reference ID/Investigator# 10761 Addison Illinois
United States Site Reference ID/Investigator# 25082 Anaheim California
United States Site Reference ID/Investigator# 15283 Arvada Colorado
United States Site Reference ID/Investigator# 19301 Atlanta Georgia
United States Site Reference ID/Investigator# 7051 Atlanta Georgia
United States Site Reference ID/Investigator# 7109 Atlanta Georgia
United States Site Reference ID/Investigator# 6742 Aurora Illinois
United States Site Reference ID/Investigator# 6748 Aurora Illinois
United States Site Reference ID/Investigator# 7085 Aurora Colorado
United States Site Reference ID/Investigator# 11925 Aventura Florida
United States Site Reference ID/Investigator# 7104 Bellaire Texas
United States Site Reference ID/Investigator# 7128 Belleville Illinois
United States Site Reference ID/Investigator# 8103 Bloomington Minnesota
United States Site Reference ID/Investigator# 15861 Boynton Beach Florida
United States Site Reference ID/Investigator# 15121 Brooklyn Center Minnesota
United States Site Reference ID/Investigator# 7060 Carrollton Texas
United States Site Reference ID/Investigator# 6747 Chandler Arizona
United States Site Reference ID/Investigator# 6751 Chicago Illinois
United States Site Reference ID/Investigator# 6847 Chicago Illinois
United States Site Reference ID/Investigator# 6849 Chicago Illinois
United States Site Reference ID/Investigator# 6867 Chicago Illinois
United States Site Reference ID/Investigator# 7049 Chicago Illinois
United States Site Reference ID/Investigator# 7069 Chicago Illinois
United States Site Reference ID/Investigator# 14321 Cincinnati Ohio
United States Site Reference ID/Investigator# 21355 Cincinnati Ohio
United States Site Reference ID/Investigator# 7065 Cincinnati Ohio
United States Site Reference ID/Investigator# 7071 Cincinnati Ohio
United States Site Reference ID/Investigator# 7074 Cincinnati Ohio
United States Site Reference ID/Investigator# 7100 Cincinnati Ohio
United States Site Reference ID/Investigator# 21347 Corona California
United States Site Reference ID/Investigator# 15282 Dallas Texas
United States Site Reference ID/Investigator# 6745 Dallas Texas
United States Site Reference ID/Investigator# 7083 Dallas Texas
United States Site Reference ID/Investigator# 7110 Dallas Texas
United States Site Reference ID/Investigator# 7127 Dallas Texas
United States Site Reference ID/Investigator# 7326 Dawsonville Georgia
United States Site Reference ID/Investigator# 7075 Dayton Ohio
United States Site Reference ID/Investigator# 7325 Decatur Georgia
United States Site Reference ID/Investigator# 21356 Deer Park Texas
United States Site Reference ID/Investigator# 14422 Deerfield Beach Florida
United States Site Reference ID/Investigator# 19281 Delray Beach Florida
United States Site Reference ID/Investigator# 6749 Denver Colorado
United States Site Reference ID/Investigator# 7077 Denver Colorado
United States Site Reference ID/Investigator# 7057 Dunwoody Georgia
United States Site Reference ID/Investigator# 7101 Dunwoody Georgia
United States Site Reference ID/Investigator# 7050 Edina Minnesota
United States Site Reference ID/Investigator# 7084 Edina Minnesota
United States Site Reference ID/Investigator# 7076 Erlanger Kentucky
United States Site Reference ID/Investigator# 11923 Fort Worth Texas
United States Site Reference ID/Investigator# 21483 Garden Grove California
United States Site Reference ID/Investigator# 7089 Gilbert Arizona
United States Site Reference ID/Investigator# 7092 Golden Colorado
United States Site Reference ID/Investigator# 7093 Gurnee Illinois
United States Site Reference ID/Investigator# 6746 Hazel Crest Illinois
United States Site Reference ID/Investigator# 7063 Henderson Nevada
United States Site Reference ID/Investigator# 7070 Henderson Nevada
United States Site Reference ID/Investigator# 20881 Hollywood Florida
United States Site Reference ID/Investigator# 11323 Houston Texas
United States Site Reference ID/Investigator# 21354 Houston Texas
United States Site Reference ID/Investigator# 21358 Houston Texas
United States Site Reference ID/Investigator# 26482 Houston Texas
United States Site Reference ID/Investigator# 7079 Houston Texas
United States Site Reference ID/Investigator# 7096 Houston Texas
United States Site Reference ID/Investigator# 7126 Houston Texas
United States Site Reference ID/Investigator# 7130 Houston Texas
United States Site Reference ID/Investigator# 7321 Houston Texas
United States Site Reference ID/Investigator# 8186 Houston Texas
United States Site Reference ID/Investigator# 21351 Huntington Beach California
United States Site Reference ID/Investigator# 11924 Irving Texas
United States Site Reference ID/Investigator# 13863 Irving Texas
United States Site Reference ID/Investigator# 24802 Kettering Ohio
United States Site Reference ID/Investigator# 20882 Kissimmee Florida
United States Site Reference ID/Investigator# 21346 Laguna Hills California
United States Site Reference ID/Investigator# 7106 Las Vegas Nevada
United States Site Reference ID/Investigator# 7119 Las Vegas Nevada
United States Site Reference ID/Investigator# 7129 Las Vegas Nevada
United States Site Reference ID/Investigator# 7518 Las Vegas Nevada
United States Site Reference ID/Investigator# 7721 Littleton Colorado
United States Site Reference ID/Investigator# 7722 Littleton Colorado
United States Site Reference ID/Investigator# 21341 Long Beach California
United States Site Reference ID/Investigator# 7068 Mason Ohio
United States Site Reference ID/Investigator# 7099 McKinney Texas
United States Site Reference ID/Investigator# 18503 Melbourne Florida
United States Site Reference ID/Investigator# 19321 Melbourne Florida
United States Site Reference ID/Investigator# 21353 Melbourne Florida
United States Site Reference ID/Investigator# 6743 Melrose Park Illinois
United States Site Reference ID/Investigator# 7097 Mesa Arizona
United States Site Reference ID/Investigator# 7090 Naperville Illinois
United States Site Reference ID/Investigator# 19121 New Braunfels Texas
United States Site Reference ID/Investigator# 21342 Norwalk California
United States Site Reference ID/Investigator# 6750 Oak Brook Illinois
United States Site Reference ID/Investigator# 6788 Oak Park Illinois
United States Site Reference ID/Investigator# 26244 Pearland Texas
United States Site Reference ID/Investigator# 26394 Phoenix Arizona
United States Site Reference ID/Investigator# 7105 Plano Texas
United States Site Reference ID/Investigator# 11324 Roswell Georgia
United States Site Reference ID/Investigator# 6741 Roswell Georgia
United States Site Reference ID/Investigator# 13182 Saint Louis Missouri
United States Site Reference ID/Investigator# 14423 Saint Louis Missouri
United States Site Reference ID/Investigator# 14541 Saint Louis Missouri
United States Site Reference ID/Investigator# 6740 Saint Louis Missouri
United States Site Reference ID/Investigator# 6860 Saint Louis Missouri
United States Site Reference ID/Investigator# 7053 Saint Louis Missouri
United States Site Reference ID/Investigator# 6784 Saint Peters Missouri
United States Site Reference ID/Investigator# 18402 San Antonio Texas
United States Site Reference ID/Investigator# 22947 San Antonio Texas
United States Site Reference ID/Investigator# 7052 San Antonio Texas
United States Site Reference ID/Investigator# 7058 San Antonio Texas
United States Site Reference ID/Investigator# 7061 San Antonio Texas
United States Site Reference ID/Investigator# 7062 San Antonio Texas
United States Site Reference ID/Investigator# 7320 San Antonio Texas
United States Site Reference ID/Investigator# 7914 San Antonio Texas
United States Site Reference ID/Investigator# 21321 Santa Ana California
United States Site Reference ID/Investigator# 6848 Scottsdale Arizona
United States Site Reference ID/Investigator# 7103 Suwanee Georgia
United States Site Reference ID/Investigator# 7059 Tempe Arizona
United States Site Reference ID/Investigator# 7094 Tempe Arizona
United States Site Reference ID/Investigator# 7098 Tempe Arizona
United States Site Reference ID/Investigator# 26242 Tustin California
United States Site Reference ID/Investigator# 6927 Vernon Hills Illinois
United States Site Reference ID/Investigator# 18841 Vero Beach Florida
United States Site Reference ID/Investigator# 19961 Vero Beach Florida
United States Site Reference ID/Investigator# 6744 West Palm Beach Florida
United States Site Reference ID/Investigator# 7166 West Palm Beach Florida

Sponsors (1)

Lead Sponsor Collaborator
AbbVie (prior sponsor, Abbott)

Country where clinical trial is conducted

United States, 

References & Publications (1)

Davidson M, Rosenson RS, Maki KC, Nicholls SJ, Ballantyne CM, Setze C, Carlson DM, Stolzenbach J. Study design, rationale, and baseline characteristics: evaluation of fenofibric acid on carotid intima-media thickness in patients with type IIb dyslipidemia — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of Change in Mean Posterior-wall Carotid Intima-media Thickness (cIMT) Rate of change (mm/year) from baseline in mean of posterior-wall carotid intima-media thickness (cIMT) of the left and right common carotid artery. The statistical model used change from baseline as the dependent variable, with time of cIMT assessment (in years) as one of the factors in the model. The between-group difference in the rate of change was based on the parameter coefficient for the time-by-treatment interaction. The within-group rate of change was obtained from estimate statements within the repeated measures analysis. cIMT was measured using non-invasive ultrasound. Baseline, 6 months, 12 months, 18 months, and 24 months
Secondary Rate of Change in Mean of Maximal Posterior-wall Carotid Intima-media Thickness (cIMT) Rate of change (mm/year) from baseline in mean of maximal posterior-wall carotid intima-media thickness (cIMT) of the left and right common carotid artery. The statistical model used change from baseline as the dependent variable, with time of cIMT assessment (in years) as one of the factors in the model. The between-group difference in the rate of change was based on the parameter coefficient for the time-by-treatment interaction. The within-group rate of change was obtained from estimate statements within the repeated measures analysis. cIMT was measured using non-invasive ultrasound. Baseline, 6 months, 12 months, 18 months, and 24 months
Secondary Rate of Change in Composite of Mean of the Mean Posterior-wall Intima-media Thickness (IMT) Rate of change (mm/year) from baseline in composite of mean of the mean posterior-wall intima-media thickness (IMT) of the left and right common carotid artery, internal carotid artery, and carotid bifurcation. The statistical model used change from baseline as the dependent variable, with time of IMT assessment (in years) as one of the factors in the model. The between-group difference in the rate of change was based on the parameter coefficient for the time-by-treatment interaction. The within-group rate of change was obtained from estimate statements within the repeated measures analysis. IMT was measured using non-invasive ultrasound. Baseline, 6 months, 12 months, 18 months, and 24 months
Secondary Rate of Change in Composite of Mean of Maximal Posterior-wall Intima-media Thickness (IMT) Rate of change (mm/year) from baseline in composite of mean of maximal posterior-wall intima-media thickness (IMT) of the left and right common carotid artery, internal carotid artery, and carotid bifurcation. The statistical model used change from baseline as the dependent variable, with time of IMT assessment (in years) as one of the factors in the model. The between-group difference in the rate of change was based on the parameter coefficient for the time-by-treatment interaction. The within-group rate of change was obtained from estimate statements within the repeated measures analysis. IMT was measured using non-invasive ultrasound. Baseline, 6 months, 12 months, 18 months, and 24 months
Secondary Rate of Change in Composite of Mean of Maximal Posterior-wall and Anterior-wall Intima-media Thickness (IMT) Rate of change (mm/year) from baseline in composite of mean of maximal posterior-wall and anterior-wall intima-media thickness (IMT) of the left and right common carotid artery, internal carotid artery, and carotid bifurcation. The statistical model used change from baseline as the dependent variable, with time of IMT assessment (in years) as one of the factors in the model. The between-group difference in the rate of change was based on the parameter coefficient for the time-by-treatment interaction. The within-group rate of change was obtained from estimate statements within the repeated measures analysis. IMT was measured using non-invasive ultrasound. Baseline, 6 months, 12 months, 18 months, and 24 months
See also
  Status Clinical Trial Phase
Recruiting NCT06030596 - SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
Completed NCT04080700 - Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
Recruiting NCT03810599 - Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study N/A
Recruiting NCT06002932 - Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions. N/A
Not yet recruiting NCT06032572 - Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE) N/A
Recruiting NCT04242134 - Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions N/A
Recruiting NCT05308719 - Nasal Oxygen Therapy After Cardiac Surgery N/A
Completed NCT04556994 - Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients. N/A
Recruiting NCT05846893 - Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease N/A
Recruiting NCT06027788 - CTSN Embolic Protection Trial N/A
Recruiting NCT05023629 - STunning After Balloon Occlusion N/A
Completed NCT04941560 - Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
Completed NCT04006288 - Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease Phase 4
Completed NCT01860274 - Meshed Vein Graft Patency Trial - VEST N/A
Recruiting NCT06174090 - The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients N/A
Completed NCT03968809 - Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
Terminated NCT03959072 - Cardiac Cath Lab Staff Radiation Exposure
Recruiting NCT04566497 - Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up. N/A
Recruiting NCT05065073 - Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography Phase 4
Completed NCT05096442 - Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions N/A

External Links